Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

treatment outcomes

  • You have access
    Impact of ABCG2 rs2231142(421C>A) Variant on the Clinical Outcomes of Patients With EGFR-mutated Non-small Cell Lung Cancer Treated With Gefitinib: A Comprehensive Meta-analysis
    FRANCISCO CEZAR AQUINO DE MORAES, MARIA EDUARDA CAVALCANTI SOUZA, EMANUELE ROCHA DA SILVA, MICHELE KREUZ and ROMMEL MARIO RODRIGUEZ BURBANO
    Anticancer Research December 2024, 44 (12) 5361-5370; DOI: https://doi.org/10.21873/anticanres.17363
  • You have access
    Simultaneous vs. Sequential Boost for Adjuvant Breast Radiotherapy
    MARIE C. EGGERT, STEFAN JANSSEN, NATHAN Y. YU and DIRK RADES
    Anticancer Research October 2023, 43 (10) 4651-4655; DOI: https://doi.org/10.21873/anticanres.16660
  • Open Access
    Evaluation of the Impact of Smoking and Alcohol Consumption on Toxicity and Outcomes of Chemoradiation for Head and Neck Cancer
    DIRK RADES, INGA ZWAAN, STEFAN JANSSEN, NATHAN Y. YU, STEVEN E. SCHILD, CHRISTIAN IDEL, RALPH PRIES, SAMER G. HAKIM and TAMER SOROR
    Anticancer Research February 2023, 43 (2) 823-830; DOI: https://doi.org/10.21873/anticanres.16224
  • You have access
    Accelerated Fractionation Plus Chemotherapy Versus Conventionally Fractionated Radiochemotherapy for Unresectable Head-and-Neck Cancer
    DIRK RADES, CARLOS A. NARVAEZ, STEFAN JANSSEN, URSULA SCHRÖDER, KARL L. BRUCHHAGE, SAMER G. HAKIM, TOBIAS BARTSCHT and STEVEN E. SCHILD
    Anticancer Research February 2021, 41 (2) 877-884; DOI: https://doi.org/10.21873/anticanres.14840
  • You have access
    Results of Tri-Modality Therapy for Rectal Cancer in Elderly Patients
    MAXI TREDER, STEFAN JANSSEN, STEVEN E. SCHILD and DIRK RADES
    Anticancer Research November 2019, 39 (11) 6217-6222; DOI: https://doi.org/10.21873/anticanres.13830
  • You have access
    Prognostic Factors and a Survival Score in Patients Irradiated for Metastatic Epidural Spinal Cord Compression from Urothelial Carcinoma Cancer of the Bladder
    DIRK RADES, LISA SONDERMANN, LAURA MOTISI, STEFAN JANSSEN, JON CACICEDO and STEVEN E. SCHILD
    Anticancer Research December 2018, 38 (12) 6841-6846; DOI: https://doi.org/10.21873/anticanres.13058
  • You have access
    Role of Neoadjuvant Radio-chemotherapy for the Treatment of High Rectal Cancer
    MAXI TREDER, STEFAN JANSSEN, NIELS HENRIK HOLLÄNDER, STEVEN E. SCHILD and DIRK RADES
    Anticancer Research September 2018, 38 (9) 5371-5377; DOI: https://doi.org/10.21873/anticanres.12866
  • You have access
    Comparison of Two Radiotherapy Regimens for Metastatic Spinal Cord Compression: Subgroup Analyses from a Randomized Trial
    DIRK RADES, ANTONIO J. CONDE-MORENO, JON CACICEDO, BARBARA ŠEGEDIN, KARMEN STANIC, MICHAELA METZ, VOLKER RUDAT and STEVEN E. SCHILD
    Anticancer Research February 2018, 38 (2) 1009-1015;
  • You have access
    Comparison of Two Dose Levels of Stereotactic Radiosurgery for 1-3 Brain Metastases from Non-small Cell Lung Cancer
    DIRK RADES, STEFAN HUTTENLOCHER, MARKUS DAHLKE, DAGMAR HORNUNG, OLIVER BLANCK, PHAM VAN THAI, NGO THUY TRANG, MAI TRONG KHOA and STEVEN E. SCHILD
    Anticancer Research December 2014, 34 (12) 7309-7313;
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire